Christina M. Annunziata, M.D., Ph.D.
Medical Oncology Branch and Affiliates
Molecular Signaling Section
Assistant Clinical Investigator
National Cancer Institute
9000 Rockville Pike
Building 10, Room 12N226
Bethesda, MD 20892
Dr. Annunziata is a graduate of Georgetown University Medical School where she also completed graduate school and residency training in internal medicine. She came to NCI for medical oncology training in the Medical Oncology Branch. Dr. Annunziata joined the laboratory of Dr. Louis Staudt in the Metabolism Branch to investigate NF-kappaB signaling in multiple myeloma. She returned to the Medical Oncology Branch to extend her study of these molecular pathways in the ovarian cancer model, and she maintains her clinical focus in the translational clinical studies of ovarian cancer.
Dr. Annunziata holds board certifications for the practices of internal medicine and medical oncology. Dr. Annunziata is a participating member in the Gynecologic Oncology Group, the American Association for Cancer Research, the American Society for Clinical Oncology, and the Breast and Gynecologic Malignancies and Molecular Targets Faculties of CCR. She serves as course director for the Medical Ovarian Cancer Lecture Series in the Medical Oncology Branch, and has recently been appointed co-editor-in-chief of the international journal, Ovarian Diseases.
Dr. Annunziata's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with breast cancer or ovarian cancer. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.